FDA Panel Takes ‘Leap Of Faith’ In Backing Epinephrine Nasal Spray For Anaphylaxis

 
• By Brenda Sandburg
  
epinephrine
FDA advisory panel finds PK/PD data supports favorable assessment of intranasal epinephrine for treatment of anaphylaxis • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers